GGrantIndex
← Search

Creating an efficient clinical trial build system via the Clinical Trials Rapid Activation Consortium (CTRAC)

$150,000P30FY2021CANIH

University Of Wisconsin-Madison, Madison WI

Investigators

Linked publications, trials & patents

Paper 39638850Paper 39604703Paper 39580301Paper 39530524Paper 39527745Paper 39516197Paper 39484544Paper 39481346Paper 39474803Paper 39462136Paper 39452931Paper 39444276Paper 39443360Paper 39432401Paper 39414902Paper 39408582Paper 39407431Paper 39402986Paper 39399121Paper 39386576Paper 39386545Paper 39379374Paper 39374311Paper 39364328Paper 39358429Paper 39345631Paper 39335130Paper 39312186Trial NCT06608511Trial NCT06557733Trial NCT05985681Trial NCT05521698Trial NCT05107219Trial NCT03725761Trial NCT03722030Trial NCT03703492Trial NCT03656276Trial NCT03393741Trial NCT03387514Trial NCT03358563Trial NCT03356470Trial NCT03342378Trial NCT03304002Trial NCT03300557Trial NCT03209869Trial NCT03185871Trial NCT03028584Trial NCT03023202Trial NCT02955043Trial NCT02917629Trial NCT02876640Trial NCT02780401Trial NCT02719821Trial NCT02169284Trial NCT02096783Trial NCT02095145Trial NCT01999881Trial NCT01935960Trial NCT01901835Trial NCT01707004Trial NCT01625156Trial NCT01325311Trial NCT01263613Trial NCT01245205Trial NCT01243359Trial NCT01233505Trial NCT01218620Trial NCT01217450Trial NCT01158274Trial NCT01083641Trial NCT01004796Trial NCT00896974Trial NCT00666562Trial NCT00544596Trial NCT00499135Trial NCT00462969Trial NCT00415025Trial NCT00410605Trial NCT00227513Trial NCT00138203Trial NCT00109863Trial NCT00079014Trial NCT00052832Trial NCT00049712Trial NCT00036790Trial NCT00028652Trial NCT00023855Trial NCT00022412Trial NCT00005794Trial NCT00004872Patent 9867974Patent 9763597Patent 9603567Patent 9470697Patent 9161720Patent 8871458Patent 6974254Patent 6438202Patent 6114119Patent 6020178

Abstract

ABSTRACT Scientific Rationale. Childhood cancer survivors (CCS) represent a vulnerable population at high risk of medical and psychosocial sequelae of cancer and cancer treatment necessitating survivorship care supported by Children?s Oncology Group (COG) long-term follow-up guidelines. However, current data indicate that most CCS are not receiving recommended survivorship care. To date, approaches to identify receipt of guideline- concordant care fail to routinely include community and organizational factors that may influence receipt of this care. There is a critical need to develop an approach to identify receipt of guideline-concordant care in real time, incorporating CCS-generated and community and organizational-level data to explore disparities in care and ultimately support future interventions targeting the sources of those disparities. Hypothesis. We hypothesize that development of an electronic health record (EHR)-based CCS registry supplemented with patient-generated data will (1) be feasible and acceptable to CCS, (2) provide actionable identification of CCS not receiving guideline-concordant care, and (3) enable assessment of community and organizational factors associated with receipt of guideline-concordant care. Project Design. In Aim 1, our multi-disciplinary research team will draft CCS data elements to incorporate into our existing EHR-based cancer registry system, Healthy Planet (Epic Systems?). We will emphasize data elements that are not traditionally part of EHR-registries including community (e.g., neighborhood social cohesion, Area Deprivation Index) and organization factors (e.g., availability/efficacy of pediatric-to-adult care transition visits for CCS, barriers to survivorship care plan development or access). A CCS Advisory Board (n = 6-10 adult CCS or parents of CCS <18 years of age) will then review the proposed data elements over the course of 2-3 Advisory Board meetings, driving iterative revision of registry elements. Aim 2 will recruit 30 adult CCS from the EHR-based registry to input patient-generated data into the registry including self-reported community-level data and patient perspectives on organizational-level factors. Feasibility will be assessed through participation rate and data completeness. Acceptability of CCS-generated data will be assessed via participant surveys. For Aim 3, we will compare assessments of guideline-concordant care between traditional retrospective chart review and the new EHR-based registry. We will conduct exploratory analyses to assess whether community and organizational factors explain disparities in receipt of guideline-concordant care. Next Steps. Development of the proposed EHR-based registry is a necessary, first step toward the design of cancer center-level interventions to eliminate disparities and improve CCS outcomes. Once sufficient data is available, we will perform definitive analyses to identify community and organization factors related to receipt of guideline-concordant care. Subsequently, we plan to develop and test cancer center-level interventions to target identified community and organizational factors contributing to disparities in care of CCS.

View original record on NIH RePORTER →